Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Amylyx Pharmaceuticals, Inc.
Business Segments
Products & Services
Research And Development Expense Excluding Acquired In Process Cost
Research And Development Expense Excluding Acquired In Process Cost
Amylyx Pharmaceuticals, Inc.
·
Products & Services
·
3 segments
·
Rolls up to
R&D
Breakdown
Segments
Avexitide
View metric
AMX0035PSP
View metric
Other Programs
View metric
Quarterly
Annual
TTM
Segment
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Avexitide
$5.43M
$7.11M
$4.89M
$6.68M
$9.99M
Other Programs
$3.77M
$3.97M
$3.65M
$4.09M
$7.98M
AMX0035PSP
$4.56M
$7.15M
$3M
$2.56M
$649K
Total
$22.12M
$27.22M
$19.86M
$21.21M
$27.61M